These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 2146349)

  • 1. Inhibition of platelet function by polymorphonuclear leukocytes.
    Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
    J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor.
    Hammerschmidt DE; Kotasek D; McCarthy T; Huh PW; Freyburger G; Vercellotti GM
    J Lab Clin Med; 1988 Aug; 112(2):254-63. PubMed ID: 2840477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human endothelial cells inhibit granulocyte aggregation in vitro.
    Zimmerman GA; Klein-Knoeckel D
    J Immunol; 1986 May; 136(10):3839-47. PubMed ID: 3009611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ethanol on pathways of platelet aggregation in vitro.
    Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
    Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet aggregation induced by the endoperoxide analogue U46619 is inhibited by polymorphonuclear leukocyte ADPase activity.
    Zatta A; Pandolfo L; Caparrotta L; Prosdocimi M; Dejana E; Del Maschio A
    Arterioscler Thromb; 1993 May; 13(5):696-701. PubMed ID: 8485121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphonuclear leukocyte-dependent modulation of platelet function: effect of cloricromene.
    Zatta A; Prosdocimi M; Bazzoni G; Dejana E; Del Maschio A
    Eur J Pharmacol; 1991 May; 198(1):97-100. PubMed ID: 1833211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A stable leukocyte-derived factor inhibits platelet aggregation.
    Liu JJ; Xie B; Smith IL; Johnston CI; Buxton BF
    Biochem Biophys Res Commun; 1994 Jun; 201(2):878-82. PubMed ID: 8003026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human blood platelets, PMN leukocytes and their interactions in vitro. Responses to selective and non-selective stimuli.
    Drábiková K; Jancinová V; Nosál R; Danihelová E
    Gen Physiol Biophys; 2000 Dec; 19(4):393-404. PubMed ID: 11409842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet modulation of neutrophil superoxide anion production.
    Moon DG; van der Zee H; Weston LK; Gudewicz PW; Fenton JW; Kaplan JE
    Thromb Haemost; 1990 Feb; 63(1):91-6. PubMed ID: 2160133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the polyamine-spermine on agonist-induced human platelet activation--specific inhibition of "aggregation-independent" events induced by thrombin, but not by collagen, thromboxane mimetic, phorbol ester or calcium ionophore.
    Joseph S; Krishnamurthi S; Kakkar VV
    Thromb Haemost; 1987 Apr; 57(2):191-5. PubMed ID: 3110996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of plumbagin on platelet aggregation and platelet-neutrophil interactions.
    Shen Z; Dong Z; Cheng P; Li L; Chen Z; Liu J
    Planta Med; 2003 Jul; 69(7):605-9. PubMed ID: 12898414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G protein activation and mediator release from human neutrophils and platelets after stimulation with sodium fluoride and receptor-mediated stimuli.
    Brom C; Brom J; König W
    Immunology; 1991 Jul; 73(3):287-92. PubMed ID: 1652553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation.
    Werner MH; Senzel L; Bielawska A; Khan W; Hannun YA
    Mol Pharmacol; 1991 Apr; 39(4):547-56. PubMed ID: 2017154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
    Rendu F; Bachelot C; Molle D; Caen J; Guez D
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents.
    Del Maschio A; Evangelista V; Rajtar G; Chen ZM; Cerletti C; De Gaetano G
    Am J Physiol; 1990 Mar; 258(3 Pt 2):H870-9. PubMed ID: 2156456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes.
    Piccardoni P; Evangelista V; Piccoli A; de Gaetano G; Walz A; Cerletti C
    Thromb Haemost; 1996 Nov; 76(5):780-5. PubMed ID: 8950790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of PAR4 signaling mediates ethanol-induced attenuation of platelet function in vitro.
    Kasuda S; Sakurai Y; Shima M; Morimura Y; Kudo R; Takeda T; Ishitani A; Yoshioka A; Hatake K
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1608-14. PubMed ID: 16930224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.